Transfusion management in critically ill patients

Area of Science:

• Critical Care Medicine
• Hematology
• Transfusion Medicine

Background:

• Blood component transfusion is a frequent intervention for critically ill patients, aiming to improve oxygen delivery and manage coagulopathy.
• Evidence over two decades supports restrictive transfusion strategies for most critically ill populations.
• Individualized transfusion decisions are crucial for patients with ischemia-sensitive organs.

Purpose of the Study:

• To review current evidence and best practices for blood component transfusion in critical illness.
• To highlight the balance between transfusion benefits and risks.
• To emphasize individualized transfusion strategies based on patient condition.

Main Methods:

• Review of randomized trials and systematic reviews on transfusion strategies.
• Discussion of management of bleeding and coagulopathy, including platelet transfusion, factor replacement, and antifibrinolytic therapy.
• Inclusion of the role of viscoelastic assays in guiding hemostatic therapy.

Main Results:

• Restrictive transfusion strategies are generally supported by evidence for most critically ill patients.
• Higher transfusion thresholds may be necessary for patients with acute myocardial infarction or neurologic injury.
• Viscoelastic assays are increasingly utilized for targeted hemostatic therapy.

Conclusions:

• Optimal transfusion practice necessitates balancing physiological needs with transfusion risks.
• Evidence-based thresholds should be applied within the specific clinical context of critical illness.
• Individualized care is paramount in transfusion decisions for critically ill patients.